← Evidence map

ArticleHemaSphere2020

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.

Heinz Gisslinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33134869